Evaluation of OSSIX® Bone in Sinus Elevation

Inclusion criteria

• Patient requiring vertical elevation of the maxillary sinus.
• Residual alveolar bone height of edentulous maxilla below the floor of the maxillary sinus of > 4-5mm.
• Males and females between 30-80 years old
• Patients with healthy periodontal conditions (Treated periodontitis, PI<25%, BoP<25%)
• Patients that are willing to sign an informed consent and participate in a clinical study
• Generally fit and healthy and able to undergo oral surgical procedures under local anesthesia.
• Teeth at the surgical site which required removal were extracted a minimum of 12 weeks prior to sinus floor elevation.

Exclusion criteria

• Patients who smoke over 5 cigarettes/day
• Pregnancy (confirmed by verbal inquiry)
• Chronic systemic pathologies (e.g. diabetes) and neoplastic of the Oro-Facial District 4.
• Patients taking bisphosphonates
• Any sites where an implant already failed sites
• Untreated Periodontitis
• Dental sites with acute infections
• Chronic inflammatory diseases of the oral cavity
• Autoimmune diseases (cortisone intake)
• Allergy declared to one or more medicaments to be used during treatment
• Alcoholics patients and/or drug addicts
• Patients with known collagen hypersensitivity.
• Patients with sensitivity to porcine-derived materials.
• History or malignant tumours of the maxillary sinus
• History of local radiation therapy